Dental Mercury Poses Health Risk To Pregnant Women And Children, Admits FDA (Medical News Today)
Following the settlement of a lawsuit earlier this week, the US Food and Drug Administration (FDA) has updated its consumer advice on mercury amalgam to say that it poses health risks to pregnant women, children, and the unborn.

Mesoblast Limited (ASX:MSB) Announce United States FDA Clears Phase 2 Trial For Congestive Heart Failure (Medical News Today)
Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(USOTC:MBLTY)(PINK:MEOBF), announced that the United States Food and Drug Administration (US FDA) had cleared an Investigational New Drug (IND) submission by its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 trial of the stem cell platform technology for treating patients with congestive heart failure.